Navigation Links
MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products

WILMINGTON, Delaware, December 16 /PRNewswire/ -- While many of the pharma companies are struggling to outsource their accurate forecast models for new and inmarket drugs, MarketsandMarkets on the other hand provides integrated patient-based forecast solutions to various players. These pharma forecasting solutions are designed for phase I, phase II, as well as phase III. These have a substantial impact on pricing, launch, product life cycle management, market entry strategy, manufacturing planning, sales force, promotion, and planning. The leading pharma companies now endorse the forecast solution provided by MarketsandMarkets as the accurate forecast model, comprising of significant cost benefit analysis for an annual contract basis. The forecasts are based on epidemiology and actual patients on drugs. The primary and secondary research analytics underlying the forecast include:

    - Epidemiology analysis
    - Treated patients best fit trending
    - Polypharmacy ratio analysis
    - Competitive landscape analysis
    - Analogue analysis for uptake, time to peak, and generic erosion
    - Conjoint / discrete choice / attribute analysis
    - Calibration based on actual sales and impact of various events

The treated patient pool potential is determined by prevalence, incidence, diagnosis, treatment, cure, and mortality rate. The treated patient pool is also back-calculated simultaneously from historic and present product sales. Trending and smoothening takes into account seasonality and the impact of other events on sale. The conjoint / discrete choice analysis uses primary research to estimate peak patient share for new products. In absence of primary research due to budget / time constraints, an attribute analysis is done using secondary research and consumer inputs to estimate peak patient share for new products.

The peak patient share calculation mechanism is calibrated based on shares of existing products. Ratio of treated patient pool, based on patient on products and epi, gives polypharmacy ratio. Analogues are identified based on disease area, TPP, MoA, order of entry, and market dynamics to estimate time to peak, shape of uptake curve, generic erosion, and impact of other events. Share exchange / cannibalization is done based on fair-share approach or inputs from brand team along with secondary and primary research.

Simple and transparent VB- and Excel-based forecast models: models are developed based on forecast complexity and the functional need of end-user. Our team has expertise in designing and developing VB- and Excel-based forecast / market models.

Strong quality checks: - quality checks are built up at each stage to ensure foolproof estimates, including triangulation of epi data from multiple sources, calibration based on polypharmacy and actual historic sale, calibration of peak patient share estimation model or peak patient share based on share. Quality checks embedded in the Excel / VB formula in the forecast model.

We have strong team of analysts with experience in executing advanced forecasting projects for both pipeline and in-market products for the top pharma companies globally.

    For more details, click on:

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at

    Ms. Sunita
    108, West 13th Street,
    Wilmington, DE, 19801
    County of New Castle
    Tel: +1-888-989-8004

SOURCE MarketsandMarkets

SOURCE MarketsandMarkets
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MarketsandMarkets: Global Neurostimulation Market Worth US$10.2 Billion by 2014
2. MarketsandMarkets: Global Home health Care Market Worth US$159.6 Billion by 2014
3. MarketsandMarkets: Global Emerging Lighting Technologies Market Worth US$112.2 Billion by 2014
4. MarketsandMarkets: Global Biomarker Market Worth US$ 20.5 Billion by 2014
5. MarketsandMarkets: Top Ten Medical Device Technologies Market Worth $454.3 Billion by 2014
6. Frost & Sullivan to Hold Web Conference on Integrated Hospital Pharmacy Information Systems - How to Maneuver towards Growth Potential
7. EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content
8. InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery
9. Amedisys Selects MetricStream for Integrated Enterprise-wide GRC
10. Health Integrated Announces Turnkey Model of Care Program for Special Needs Health Plans
11. Glide Health Corporation and Integrated Medical Professionals Announce Partnership to Deploy the Glide Mobile Health Platform to Over One Million Patients and Over 100 Physicians in 50 Locations
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, ... organization dedicated to helping service members that have been wounded in battle and their ...
(Date:6/24/2016)... ... June 24, 2016 , ... Advanced Plastic Surgery Institute ( ... as its official Medspa Sponsor. Dr. Josh Olson, a board-certified plastic surgeon, owns ... Dr. Olson says the decision to support the pageant in an official capacity ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
Breaking Medicine Technology: